Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Edison Investment Research-Archiv vom 27.05.2021

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
27.05.21Oxford Biomedica - Driving innovation in a thriving CGT industry234Oxford Biomedica (OXB) is one of few global lentiviral vector manufacturers with capacity in a thriving cell and gene therapy industry, and its FY20 results highlight strong operational progress throughout...
► Artikel lesen
27.05.21Datatec - Robust underlying performance across the board271Datatec delivered a strong operational performance across all divisions in FY21, despite the challenges of COVID-19 and emerging market weakness. The group reported revenues of US$4.1bn down 2.5% y-o-y...
► Artikel lesen
27.05.21La Doria - Looking ahead with confidence351La Doria has posted another strong quarter, with revenue and EBITDA growth notwithstanding the strong base. Revenue growth was mainly price-driven, and mostly driven by the UK business. While the outlook...
► Artikel lesen
27.05.21Avon Rubber - Protection is the name of the game328The benefits of the three-pronged growth strategy are reflected in Avon Rubber's H121 performance, which delivered strong overall growth in revenues and adjusted group profitability driven by a strong...
► Artikel lesen
27.05.21SymBio Pharmaceuticals - The first whole quarter of internal SymBio sales166SymBio reported Q121 sales of ¥1.42bn of its drug Treakisym (bendamustine) for hematologic malignancies. This is the first quarter in which the product is being sold by SymBio directly, and it marks...
► Artikel lesen
27.05.21Abliva - KL1333 ready for pivotal Phase II/III trial274Just few months in, Abliva's new CEO has already spearheaded a successful private placement (SEK80m gross in March 2021), which will now support the preparations for the pivotal KL1333 trial in primary...
► Artikel lesen